Real-time enrollment status for this sars cov-2 post-acute sequelae clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:50 PM UTC
| NCT Number | NCT05656105 |
| Recruiting Status | Recruiting |
| Condition | SARS CoV-2 Post-Acute Sequelae |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT05656105 is currently recruiting participants. This early_phase1 study for sars cov-2 post-acute sequelae is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05656105 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05656105 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.